Clinical Trial: Stopping Strep Throat With Antibodies in Healthy Adults.

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07864350) titled 'Stopping Strep Throat With Antibodies in Healthy Adults.' on Sept. 28.

Brief Summary: This research group has previously established a safe and reliable model of experimental human streptococcal pharyngitis (a 'strep throat' human challenge model). The CHIVAS-IgG study will use this model to understand the ways in which antibodies help protect humans against strep throat infections.

Carefully screened healthy adults who are at very low risk of complicated strep disease will be admitted to a clinical trials unit where they will be randomly allocated to receive a licensed commercial 'intravenous immunoglobulin' product that is a mixtu...